rediff.com
e.g. Tata motors, Reliance MF, 500570
Oxygenta Pharmaceutical Ltd - Board Meeting Outcome for Outcome Of Board Meeting For Submission Of Un-Audited Financial Results Under Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015.
Download announcement < Back
14 Aug 2024
This is to inform you that the Board of Directors of the Company at its meeting held on this day i.e.,14th August, 2024 has, inter alia, approved Un-Audited Financial Results for the First Quarter ended on 30% June, 2024 as recommended by the Audit Committee and reviewed by the Statutory Auditors. Further please find enclosed herewith the following documents in terms of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015: 1. Un-Audited Financial Results of the Company for the First Quarter ended on 30th June, 2024. 2. Limited Review Report for the Un-Audited Standalone Financial Results issued for the First Quarter ended on 30th June, 2024. The meeting commenced at 05.00 P.M. and concluded at 08.00 P.M.
View all announcements for Oxygenta Pharmaceutical Ltd Source: BSE India